Xenomics Inc - NY New York, New York City 10170

Xenomics Inc entered the industry of Commercial Biotechnical Research in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Bruce A Huebner by calling (909) 364-8016 during business hours. You can also write to the business’ Single Location at 420 Lexington Avenue Room 1701, New York City, New York NY 10170. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Xenomics Inc
Representative: Bruce A Huebner
Place of Business: 420 Lexington Avenue Room 1701, New York City, NY 10170
Contact Number: (909) 364-8016
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2002
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Xenomics Inc is a company operating from New York, New York providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2002 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Xenomics Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Bruce A Huebner at (909) 364-8016 for related queries, or to locate its Single Location using the coordinates 40.752425,-73.97554.

The Single Location can also be found at the street address 420 Lexington Avenue Room 1701 in New York City, New York 10170 and can be engaged online through the company website at , the company Twitter , and Facebook page .